These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28315450)

  • 1. Phospholipid oxidation and carotenoid supplementation in Alzheimer's disease patients.
    Ademowo OS; Dias HKI; Milic I; Devitt A; Moran R; Mulcahy R; Howard AN; Nolan JM; Griffiths HR
    Free Radic Biol Med; 2017 Jul; 108():77-85. PubMed ID: 28315450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Mitigation of Oxidized Phospholipid-Mediated Mitochondrial Dysfunction in Neuronal Cells by Oxocarotenoids.
    Ademowo OS; Dias IHK; Diaz-Sanchez L; Sanchez-Aranguren L; Stahl W; Griffiths HR
    J Alzheimers Dis; 2020; 74(1):113-126. PubMed ID: 31985464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial.
    Nolan JM; Loskutova E; Howard A; Mulcahy R; Moran R; Stack J; Bolger M; Coen RF; Dennison J; Akuffo KO; Owens N; Power R; Thurnham D; Beatty S
    J Alzheimers Dis; 2015; 44(4):1157-69. PubMed ID: 25408222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined.
    Nolan JM; Mulcahy R; Power R; Moran R; Howard AN
    J Alzheimers Dis; 2018; 64(2):367-378. PubMed ID: 29945352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.
    Nolan JM; Loskutova E; Howard AN; Moran R; Mulcahy R; Stack J; Bolger M; Dennison J; Akuffo KO; Owens N; Thurnham DI; Beatty S
    J Alzheimers Dis; 2014; 42(4):1191-202. PubMed ID: 25024317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular pigment carotenoids in the retina and occipital cortex are related in humans.
    Vishwanathan R; Schalch W; Johnson EJ
    Nutr Neurosci; 2016; 19(3):95-101. PubMed ID: 25752849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
    Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers.
    Wang MX; Jiao JH; Li ZY; Liu RR; Shi Q; Ma L
    Atherosclerosis; 2013 Apr; 227(2):380-5. PubMed ID: 23398944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.
    Flieger J; Forma A; Flieger W; Flieger M; Gawlik PJ; Dzierżyński E; Maciejewski R; Teresiński G; Baj J
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer's Disease.
    Dorey CK; Gierhart D; Fitch KA; Crandell I; Craft NE
    J Alzheimers Dis; 2023; 94(1):1-17. PubMed ID: 35988225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers.
    Graydon R; Hogg RE; Chakravarthy U; Young IS; Woodside JV
    Br J Nutr; 2012 Jul; 108(2):334-42. PubMed ID: 22313522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults.
    Min JY; Min KB
    Dement Geriatr Cogn Disord; 2014; 37(3-4):246-56. PubMed ID: 24247062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses.
    Olmedilla B; Granado F; Southon S; Wright AJ; Blanco I; Gil-Martinez E; van den Berg H; Thurnham D; Corridan B; Chopra M; Hininger I
    Clin Sci (Lond); 2002 Apr; 102(4):447-56. PubMed ID: 11914107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
    Stringham JM; Stringham NT
    Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotenoid consumption is related to lower lipid oxidation and DNA damage in middle-aged men.
    Cocate PG; Natali AJ; Alfenas RC; de Oliveira A; dos Santos EC; Hermsdorff HH
    Br J Nutr; 2015 Jul; 114(2):257-64. PubMed ID: 26079483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Effects of Prenatal Carotenoid Supplementation in the Mother and her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial -Report Number 1.
    Addo EK; Allman SJ; Arunkumar R; Gorka JE; Harrison DY; Varner MW; Bernstein PS
    J Nutr; 2023 Aug; 153(8):2205-2215. PubMed ID: 37247819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era.
    Bhosale P; Zhao DY; Bernstein PS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):543-9. PubMed ID: 17251448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.
    Nolan JM; Power R; Howard AN; Bergin P; Roche W; Prado-Cabrero A; Pope G; Cooke J; Power T; Mulcahy R
    J Alzheimers Dis; 2022; 90(1):233-249. PubMed ID: 36093704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary modulation of lens zeaxanthin in quail.
    Dorey CK; Granata L; Nichols CR; Cheng KM; Craft NE
    Exp Eye Res; 2005 Oct; 81(4):464-77. PubMed ID: 15913607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells.
    Fruhwirth GO; Moumtzi A; Loidl A; Ingolic E; Hermetter A
    Biochim Biophys Acta; 2006 Sep; 1761(9):1060-9. PubMed ID: 16904371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.